Pilot study - Cimetidine enhances lymphocyte infiltration of human colorectal carcinoma: Results of a small randomized control trial

Cancer

Volumn 80, Issue 1, 1997, Pages 15-21

  Adams, Warwick J ^a   Morris, David L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Cimetidine; Colorectal carcinoma; Histamine; Lymphocytes; Tumor infiltrating

Indexed keywords

CIMETIDINE;

ADULT; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CARCINOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTIVE SURGERY; FEMALE; HISTAMINE BLOOD LEVEL; HUMAN; IMMUNE FUNCTION TEST; IMMUNE RESPONSE; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE;

AGED; CIMETIDINE; COLORECTAL NEOPLASMS; FEMALE; HISTAMINE; HISTAMINE H2 ANTAGONISTS; HUMANS; IMMUNITY, CELLULAR; LIFE TABLES; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; PILOT PROJECTS; PREOPERATIVE CARE;

EID: 0030925013     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970701)80:1<15::AID-CNCR3>3.0.CO;2-E     Document Type: Article

References (30)

1. Kumar A, Cleveland R. Immunoregulatory effects of cimetidine: inhibition of suppressor effector cell function in vivo. Immunopharmacol Immunotoxicol 1988;10:327-32.
2. Gifford M, Ferguson R, Voss B. Cimetidine reduction of tumour formation in mice. Lancet 1981;1:638-9.
3. Osband M, Hamilton D, Shen Y-J, Cohen E, Shlesinger M, Laven P, et al. Successful immunotherapy with cimetidine in mice. Lancet 1981;1:636-8.
4. Kikuchi Y, Oomori K, Kiawa I, Kato K. Effects of cimetidine on growth and immune function in nude mice bearing human ovarian carcinoma. J Natl Cancer Inst 1985;74:495-8.
5. Tonnesen H, Knigge U, Bulow S, Damm P, Fischermon K, Hesselfeldt P, et al. Effect of cimetidine on survival after gastric cancer. Lancet 1988;2:990-1.
6. Burtin C, Noirot C, Scheinmann P, Galoppin L, Sabolovic D, Bernard P. Clinical improvement in advanced cancer disease after treatment combining histamine and H2-antihistaminics (Ranitidine and Cimetidine). Eur J Cancer Clin Oncol 1988;24:161-7.
7. Adams W, Lawson J, Morris D. Cimetidine inhibits in vivo and in vitro growth of human colon cancer and reverses histamine stimulated in vitro and in vivo growth. Gut 1994; 35:1632-6.
8. Watson S, Wilkinson L, Robertson J, Hardcastle J, Stimulatory effect of histamine on the growth of human gastric tumour cells: reversal by cimetidine. Gut 1991;32:A589-90.
9. Bartholeyns J, Bouclier M. Involvement of histamine in growth of mouse and rat tumours: antitumoral properties of monofluoromethylhistidine, an enzyme activated irreversible inhibitor of histidine decarboxylase. Cancer Res 1984;44:639-45.
10. Siegers C, Hilti D, Stich R. Cimetidin hemmt das tumorzell- wachstum. Therapiewoche 1995;36:2110-4.
11. Adams W, Morris D, Ross W, Lubowski D, Kira D, Peters L. Cimetidine preserves immune function after colonic resection for cancer. Aust N Z J Surg 1994;64:847-52.
12. Hansbrough J, Zapata-Sirvent R, Bender E. Prevention of alterations in postoperative lymphocyte subpopulations by cimetidine and ibuprofen. Am J Surg 1986;151:249-55.
13. Nielsen H, Moesgaard F, Kehlet H. Ranitidine for prevention of postoperative suppression of delayed hypersensitivity. Am J Surg 1989;157:291-4.
14. Adams W, Morris D. Short-course cimetidine and survival with colorectal cancer. Lancet 1994;344:1768-9.
15. Svendsen LB, Ross C, Knigge U, Frederiksen HJ, Graversen P, Kjaergard J, Luke M, Stimpel H, Sparse BH. Cimetidine as an adjuvant treatment in colorectal cancer. A double- blind randomised pilot study. Dis Colon Rectum 1995;38: 514-8.
16. Matsumoto S. Cimetidine and survival with colorectal cancer. Lancet 1995;346:115.
17. Jass J. A new prognostic classification of rectal cancer. Lancet 1987;1:1303-6.
18. Harrison JC, Dean PJ, El-Zeky F, Vander Zwaag R. From Dukes through Jass: pathological prognostic indicators in rectal cancer. Hum Pathol 1994;25:498-505.
19. Davis N, Newland R. The reporting of colorectal cancer: the Australian clinico-pathological staging system. Aust N Z J Surg 1982;52:395-7.
20. Maluish A, Strong D. Lymphocyte proliferation. In: Rose N, Freidman H, Fahey J. editors. Manual of clinical laboratory immunology. Washington DC: American Society of Microbiology, 1986;274-81.
21. Arunlakshana O, Schild H. Some quantitative uses of drug antagonists. Br J Pharmacol 1959;14:48-58.
22. Warlow R, Bernard C. Solubilization and characterization of moderate and high affinity histamine binding sites on human blood mononuclear cells. Mol Immunol 1987;24: 27-37.
23. Chew C, Hersey S, Sachs G, Berglindh T. Histamine responsiveness of isolated gastric glands. Am J Physiol 1980;238: G312-20.
24. Hersey S. Histamine receptor in bullfrog gastric mucosa. Am J Physiol 1981;241:093-7.
25. Whitehead R, Taylor D, Evanson J, Hart I, Woolley D. Demonstration of histamine H2 receptors on human melanoma cells. Biochem Biophys Res Commun 1988;151:518-23.
26. Beer D, Matloff S, Rocklin R. The influence of histamine on immune and inflammatory responses. Adv Immunol 1984; 35:209-51.
27. Bartholeyns J, Fozard JR. Role of histamine in tumour development. Trends Pharmacol Sc 1985;232:11-5.
28. Burtin C, Scheinmann P, Salomon J, Lespinats G, Frayssinet C, Lebel B, et al. Increased tissue histamine in tumour-bearing mice and rats. Br J Cancer 1981;43:684-8.
29. Walkenstein S, Dubb J, Randolfe W, Westlake W, Stote R, Intoccia A. Bioavailability of cimetidine in man. Gastroenterology 1978;74:360-5.
30. Links M, Clingan P, Phadke K, O'Baugh J, Legge J, Adams W, et al. A randomised trial of cimetidine with 5-Fluorouracil and folinic acid in metastatic colorectal cancer. Eur J Surg Oncol 1995;21:523-5.